Clinical Trials Browser

Phase 2 × OTHER × Acquired Immunodeficiency Syndrome × Clear all

Squamous Cell Carcinoma of Head and Neck, Acquired Immunodeficiency Syndrome, Anus Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Neoplasms, Vulvar Neoplasms

NCT06519994 2025-12-17

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Phase 2 Active not recruiting

120 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT02479698 2025-11-18

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Phase 2 Recruiting

100 enrolled

Dermatologic

Acquired Immunodeficiency Syndrome, Neoplasms, Carcinoma, Merkel Cell, Encephalitis, Viral

NCT07090174 2025-10-01

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

Phase 2 Not yet recruiting

27 enrolled

GastrointestinalGynecologic

Acquired Immunodeficiency Syndrome, Anus Neoplasms, Uterine Cervical Neoplasms

NCT03304093 2023-05-12

CHIVA2

Phase 2 Completed

30 enrolled

Thoracic

Acquired Immunodeficiency Syndrome, Carcinoma, Non-Small-Cell Lung

NCT03947775 2022-06-13

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Phase 2 Not yet recruiting

228 enrolled

Gastrointestinal

Acquired Immunodeficiency Syndrome, Anus Neoplasms, Homosexuality

Clinical Trials

Potlako+

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

CHIVA2

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL